Search research articles
Contact Us
Filters
Showing results (751-760 of 757) with videos related to
Page
of 76
Sort By:
You have reached the last page of results.
This site can display upto 757 results.
Nature Communications
|
August 15, 2023
Diversity-oriented synthesis encoded by deoxyoligonucleotides
Liam Hudson, Jeremy W Mason, Matthias V Westphal, et al.
Journal of Medicinal Chemistry
|
March 5, 2025
DNA-Encoded Library Screen Identifies Novel Series of Respiratory Syncytial Virus Polymerase Inhibitors
Sean M Carney, Sandrine Grosse, Yanting Yin, et al.
Science (New York, N.Y.)
|
November 2, 2021
An oral SARS-CoV-2 M<sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19
Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Nature Communications
|
October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Journal of Medicinal Chemistry
|
February 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease
Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton, et al.
The Bone & Joint Journal
|
October 31, 2024
UK Foot and Ankle Thromboembolism (UK-FATE)
Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra, et al.
Page
of 76
Search research articles
Search
Showing results (751-760 of 757) with videos related to
Sort By:
Page
of 76
You have reached the last page of results.
This site can display upto 757 results.
Nature Communications
|
August 15, 2023
Diversity-oriented synthesis encoded by deoxyoligonucleotides
Liam Hudson, Jeremy W Mason, Matthias V Westphal, et al.
Journal of Medicinal Chemistry
|
March 5, 2025
DNA-Encoded Library Screen Identifies Novel Series of Respiratory Syncytial Virus Polymerase Inhibitors
Sean M Carney, Sandrine Grosse, Yanting Yin, et al.
Science (New York, N.Y.)
|
November 2, 2021
An oral SARS-CoV-2 M<sup>pro</sup> inhibitor clinical candidate for the treatment of COVID-19
Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.
Biorxiv : the Preprint Server for Biology
|
September 16, 2020
Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Nature Communications
|
October 19, 2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19
Britton Boras, Rhys M Jones, Brandon J Anson, et al.
Journal of Medicinal Chemistry
|
February 28, 2025
Discovery of Nirmatrelvir (PF-07321332): A Potent, Orally Active Inhibitor of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) Main Protease
Jamison B Tuttle, Christophe Allais, Charlotte M N Allerton, et al.
The Bone & Joint Journal
|
October 31, 2024
UK Foot and Ankle Thromboembolism (UK-FATE)
Jitendra Mangwani, Linzy Houchen-Wolloff, Karan Malhotra, et al.
Page
of 76